A patient treated for lymphoma with chemotherapy is now interested in a dental implant. If her lymphoma recurs, will there be any ramifications for the implant?
Wood
Bob
B
Department of Dental Oncology, Ocular and Maxillofacial Prosthetics, Princess Margaret Hospital, 610 University Avenue, Toronto, ON M5G 2M9. bob.wood@uhn.on.ca
D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D001772:Blood Cell Count; D050071:Bone Density Conservation Agents / Q000008:administration & dosage / Q000627:therapeutic use; D000075202:Contraindications; D015921:Dental Implants; D004164:Diphosphonates / Q000008:administration & dosage / Q000627:therapeutic use; D005260:Female; D006801:Humans; D007275:Injections, Intravenous; D008223:Lymphoma / Q000188:drug therapy*; D009364:Neoplasm Recurrence, Local / Q000473:pathology*; D010347:Patient Care Planning; D013997:Time Factors
D050071:Bone Density Conservation Agents; D015921:Dental Implants; D004164:Diphosphonates